As analysis and growth director at PharmExtracta, co-founder of Velleja Analysis and president of the Microbiota Worldwide Medical Society, Professor Di Pierro has devoted his profession to microbiome science, probiotic analysis and botanical nutraceuticals.
He has revealed over 250 peer-reviewed papers and developed over 400 patents associated to nutraceutical extraction applied sciences, bioavailability enhancement and microbiome modulation.
“Professor Francesco Di Pierro is a number one power in nutraceutical innovation,” mentioned Elena Fava, worldwide product supervisor at PharmExtracta. “His impression extends from scientifically validated formulations to groundbreaking analysis and schooling. His work in precision probiotics has revolutionized microbiome modulation methods [and] his experience in phytotherapy and nutraceutical formulation has established new high quality benchmarks for bioavailability and therapeutic efficacy.”
Upon accepting his award on the NutraIngredients VIP Social gathering in Barcelona, Professor Di Pierro mentioned: “Properly, I’m actually proud! It was an expertise that was each lovely and emotional.”
“The award itself is usually a fantastic recognition given to those that search to unfold tradition, innovation and acquire scientific information to help their hypotheses within the area of diet and nutraceuticals.”
A 30-year profession
After finishing his PhD in Immunology on the College of Turin, Professor Di Pierro started his profession within the Nineties. Since then, he has held a variety of roles spanning medical clinics, outpatient care, scientific publishing, and mission administration.
Presently, he holds seven posts, all whereas actively researching and creating pharmaceutical and nutraceutical improvements.
Talking on the accomplishment he’s most happy with thus far, Professor Di Pierro mentioned: “My major satisfactions have been these associated to the event of food-compatible formulation that permit for higher oral bioavailability of energetic substances of natural origin.”
“[In addition], these associated to understanding the mechanisms that designate the doable medical success of particular probiotics in relation to their tissue colonization capabilities, with explicit reference to the colonization of oral and vaginal tissues, with particular probiotics for the oral cavity, vaginal mucosa and intestines.”
With a bachelor’s diploma in pharmacy, Professor Di Pierro has additionally educated 1000’s of healthcare professionals by way of CME-accredited programs to assist practitioners higher perceive the function of nutraceuticals in medical settings. This, he says, is considered one of his key motivations for driving the nutraceutical area ahead.
“The world of medication has at all times reaped resounding successes and most of us are alive—or have a greater high quality of life—because of using these instruments,” he mentioned. “Nevertheless, highly effective medication usually have necessary negative effects. The usage of the nutraceutical, administered in add-on remedy, can preserve the ultimate yield of the remedy excessive by calming the opposed results and on the similar time prolonging the length of the medication.
“On this sense, the extremely scientific growth of some nutraceuticals, robustly studied and clinically documented, can play a task—a minimum of in pathologies that aren’t extraordinarily severe.”
‘Unparalleled contributions’ to science, business and healthcare
Now, considered one of Professor Di Pierro’s major focuses is tackling antibiotic resistance and creating protected, efficient nutraceutical options that help antibiotic therapies and cut back the necessity for extreme antibiotic use.
For some years, he has been working in the direction of isolating explicit probiotic strains to reconstruct a situation of eubiosis (balancing the intestine microbiota) in dysbiotic sufferers.
“I’m at present engaged on the event of engineered bacterial strains which have better efficiency and capability for antagonism in the direction of pathogens to scale back the necessity for antibiotic remedy,” he mentioned. “[I am also exploring] their vaccinotherapy capabilities for use in topics who don’t just like the very thought of an injectable vaccine.”
Fava, who works intently with Professor Di Pierro at PharmExtracta, says this unwavering dedication to the sector makes him a worthy winner of the award.
“For his unparalleled contributions to science, business and healthcare, Professor Di Pierro is an distinctive candidate for the NutraChampion Award 2025,” she mentioned.
